In an initial set of experiments, we performed the CCK-8 assay with glioblastoma cells treated with 10 μM PF-2545920, to which one other PDE inhibitor was added at a concentration, which, on its own, suppressed cell viability by no more than 20% (Figure 4). This evidence concerns the gene ALDH7A1 and glioblastoma.